Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

345
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
345
Physical Methods for Controlling Microbial Growth: Radiation and Filtration01:26

Physical Methods for Controlling Microbial Growth: Radiation and Filtration

1.7K
Radiation and filtration are essential tools for microbial control, targeting microorganisms through distinct mechanisms. Radiation eliminates microbes by damaging their DNA, either killing them or inhibiting their growth. Based on wavelength, radiation is classified into two types: nonionizing and ionizing radiation.Non-ionizing radiation, such as UV radiation (200–400 nm), is absorbed by DNA, causing defects that effectively disinfect surfaces, air, and water, including safety cabinets.
1.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Behavioral and functional characterization of early-stage Parkinson's disease models reveals attentional deficits and circuit-level connectivity alterations.

Experimental neurology·2026
Same author

Long-term inhibition of lysosomal glucocerebrosidase activity promotes GPX4 stability and inhibits ferroptosis in dopaminergic neurons.

Cell death & disease·2026
Same author

A case of monotherapy with intracerebroventricular anaerobic dopamine allows complete control of Parkinson's disease symptoms.

Journal of Parkinson's disease·2026
Same author

Body placement of inertial measurement units differentially affects physical activity assessment accuracy in drug-naïve Parkinson's disease.

Scientific reports·2026
Same author

Energy Stress-Induced Neuroprotection Against Ferroptosis in Dopaminergic Neurons.

Journal of neurochemistry·2026
Same author

Hepatitis C Virus and Type 2 Diabetes: Mechanisms, Clinical Impact, and Post-DAA Management.

Journal of medical virology·2026
Same journal

Identifying blood deserts in Liberia: A geospatial analysis.

Transfusion·2026
Same journal

Clot contraction of whole blood diminishes during storage and can be restored by adding platelets.

Transfusion·2026
Same journal

Investigation of the preanalytical stability of blood donor samples.

Transfusion·2026
Same journal

The need for dried plasma-Still a national issue: Where are we and recommendations.

Transfusion·2026
Same journal

Spray dried plasma manufactured from apheresis and whole blood derived plasma.

Transfusion·2026
Same journal

Identification of a novel ABO*A1.01 allele with c.562C>T (p.Arg188Cys) mutation associated with A<sub>el</sub> phenotype in a Chinese individual.

Transfusion·2026
See all related articles

Related Experiment Video

Updated: Apr 12, 2026

Tangential Flow Ultrafiltration: A &ldquo;Green&rdquo; Method for the Size Selection and Concentration of Colloidal Silver Nanoparticles
12:47

Tangential Flow Ultrafiltration: A “Green” Method for the Size Selection and Concentration of Colloidal Silver Nanoparticles

Published on: October 4, 2012

18.6K

Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro feasibility assessment.

Ming-Li Chou1, Liang-Tzung Lin1,2, David Devos3

  • 1Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Transfusion
|May 20, 2015
PubMed
Summary
This summary is machine-generated.

Nanofiltration effectively removes procoagulant microparticles (MPs) from plasma, significantly reducing its in vitro thrombogenicity. This process preserves essential coagulation factors and hemostatic activity.

More Related Videos

Microfluidic Buffer Exchange for Interference-free Micro/Nanoparticle Cell Engineering
10:27

Microfluidic Buffer Exchange for Interference-free Micro/Nanoparticle Cell Engineering

Published on: July 10, 2016

9.7K
Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing
10:19

Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing

Published on: February 13, 2016

11.9K

Related Experiment Videos

Last Updated: Apr 12, 2026

Tangential Flow Ultrafiltration: A &ldquo;Green&rdquo; Method for the Size Selection and Concentration of Colloidal Silver Nanoparticles
12:47

Tangential Flow Ultrafiltration: A “Green” Method for the Size Selection and Concentration of Colloidal Silver Nanoparticles

Published on: October 4, 2012

18.6K
Microfluidic Buffer Exchange for Interference-free Micro/Nanoparticle Cell Engineering
10:27

Microfluidic Buffer Exchange for Interference-free Micro/Nanoparticle Cell Engineering

Published on: July 10, 2016

9.7K
Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing
10:19

Three-Dimensionally Printed Microfluidic Cross-flow System for Ultrafiltration/Nanofiltration Membrane Performance Testing

Published on: February 13, 2016

11.9K

Area of Science:

  • Biomedical Engineering
  • Hematology
  • Biophysics

Background:

  • Plasma contains procoagulant microparticles (MPs) that contribute to in vitro thrombogenicity.
  • Removing MPs may reduce plasma thrombogenicity while preserving hemostatic function.

Purpose of the Study:

  • To evaluate the efficacy of 75-nm nanofiltration for removing MPs from plasma.
  • To assess the impact of MP removal on plasma in vitro thrombogenicity and coagulation factor activity.

Main Methods:

  • Nanofiltration of leukoreduced plasma using a 75-nm hollow-fiber membrane filter.
  • Assessed plasma quality via coagulation, immunochemical, and electrophoretic assays.
  • Evaluated MP removal using biophysical and functional assays, including thrombin generation assays.

Main Results:

  • Nanofiltration successfully removed over 9 logs of MPs.
  • Preserved protein and lipoprotein profiles, coagulation factor content, and global coagulation activity.
  • Markedly reduced plasma in vitro thrombogenicity, with no thrombin generation observed under low phospholipid conditions.

Conclusions:

  • 75-nm nanofiltration efficiently removes MPs from plasma.
  • This process decreases in vitro thrombogenicity without compromising protein content or hemostatic activity.
  • Further studies are required to investigate the in vivo implications for thrombotic risk and hemostatic efficacy.